Research Article
Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson’s Disease
Table 2
Baseline characteristics in the follow-up group and the discontinued follow-up group.
| | Follow-up group | Discontinued follow-up group | Z | p |
| | Age | 67.5 (64.5–69.3) | 68.0 (55.0–77.0) | −1.183 | 0.237 | | PD duration | 8.5 (3.8–13.0) | 9.0 (4.0–10.0) | −0.508 | 0.611 | | MDS-UPDRS Total (ON) | 36.5 (24.0–58.3) | 37.0 (23.0–44.0) | −1.014 | 0.310 | | MDS-UPDRS | 2.0 (0.8–3.0) | 1.0 (1.0–1.0) | −1.511 | 0.131 | | Part II-1 | | | | | | MDS-UPDRS | 1.0 (1.0–2.0) | 2.0 (1.0–2.0) | 0.000 | 1.000 | | Part III-1 | | | | | | HY | 2.0 (2.0–3.0) | 3.0 (3.0–3.0) | −1.134 | 0.257 | | Raven CPM | 32.5 (28.8–35.0) | 32.0 (30.0–34.0) | −0.271 | 0.786 |
|
|
PD: Parkinson’s disease; MDS-UPDRS: Modified Unified Parkinson’s Disease Rating Scale; HY: Hoehn & Yahr Scale stage; CPM: Colored Progressive Matrices.
|
